Abdominal Obesity, Sarcopenia, and Osteoporosis Are Associated with Frailty in Men Living with and Without HIV

Overview

Journal AIDS

Specialty Infectious Diseases

Date 2018 May 26

PMID 29794494

Citations 39

Authors

Kellie L Hawkins

Long Zhang

Derek K Ng

Keri N Althoff

Frank J Palella Jr

Lawrence A Kingsley

Lisa P Jacobson

Joseph B Margolick

Jordan E Lake

Todd T Brown

Kristine M Erlandson

Affiliations

Soon will be listed here.

Abstract

Objective: The relationships between frailty and body composition in older adults with HIV infection are poorly understood. We sought to describe associations between frailty and measures of body composition among adult men with HIV and without HIV.

Design/methods: Men with and without HIV (age 50-69 years) in the Multicenter AIDS Cohort Study (MACS) Bone Strength Substudy were included if evaluated for frailty (by Fried phenotype) and body composition [BMI, waist circumference, abdominal visceral (VAT) and subcutaneous (SAT) adipose tissue, sarcopenia, and osteopenia/osteoporosis]. All participants with HIV infection were on antiretroviral therapy. Multivariate multinomial logistic regression models were used to determine associations of frailty with body composition.

Results: A total of 399 men, including 199 men with HIV and 200 men without HIV, both with median age 60 years, constituted our study population. Frailty prevalence was 16% (men with HIV) vs. 8% (men without HIV). HIV serostatus was associated with a 2.43 times higher odds of frailty (P = 0.01). Higher waist circumference, VAT, sarcopenia, and femoral neck osteoporosis were associated with increased odds of frailty (aOR 4.18, 4.45, 4.15, and 13.6, respectively, and all P < 0.05); BMI and SAT were not. None of these measures presented a differential association with frailty by HIV serostatus (all P > 0.20).

Conclusion: Higher abdominal obesity and sarcopenia were associated with frailty among men with and without HIV. Assessment of these body composition parameters may help detect frailty in the clinical setting.

Citing Articles

The Impact of HIV on Early Brain Aging-A Pathophysiological (Re)View.

Lazar M, Moroti R, Barbu E, Chitu-Tisu C, Tiliscan C, Erculescu T J Clin Med. 2024; 13(23).

PMID: 39685490 PMC: 11642420. DOI: 10.3390/jcm13237031.

Muscle Quality and Physical Function in Men With and Without HIV.

Sun J, Ditzenberger G, Brown T, Langan S, Hsu H, Ng D J Gerontol A Biol Sci Med Sci. 2024; 79(11).

PMID: 39288937 PMC: 11497161. DOI: 10.1093/gerona/glae229.

Prevalence and associated factors related to sarcopenia in people living with HIV/AIDS.

Martins L, Oliveira E Silva M, Santos A, da Silveira V, Araujo P BMC Infect Dis. 2024; 24(1):933.

PMID: 39251940 PMC: 11385512. DOI: 10.1186/s12879-024-09845-5.

Sarcopenic obesity and pre-sarcopenia contribute to frailty in community-dwelling Italian older people: data from the FRASNET study.

Damanti S, Citterio L, Zagato L, Brioni E, Magnaghi C, Simonini M BMC Geriatr. 2024; 24(1):638.

PMID: 39085777 PMC: 11290298. DOI: 10.1186/s12877-024-05216-6.

Negative Lifestyle Factors Specific to Aging Persons Living with HIV and Multimorbidity.

Smith W J Int Assoc Provid AIDS Care. 2024; 23:23259582241245228.

PMID: 39051608 PMC: 11273731. DOI: 10.1177/23259582241245228.

References

Grant P, Kitch D, McComsey G, Collier A, Bartali B, Koletar S . Long-term body composition changes in antiretroviral-treated HIV-infected individuals. AIDS. 2016; 30(18):2805-2813. PMC: 5101158. DOI: 10.1097/QAD.0000000000001248. View

Craig C, Marshall A, Sjostrom M, Bauman A, Booth M, Ainsworth B . International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003; 35(8):1381-95. DOI: 10.1249/01.MSS.0000078924.61453.FB. View

Piggott D, Muzaale A, Varadhan R, Mehta S, Westergaard R, Brown T . Frailty and Cause-Specific Hospitalization Among Persons Aging With HIV Infection and Injection Drug Use. J Gerontol A Biol Sci Med Sci. 2016; 72(3):389-394. PMC: 6075460. DOI: 10.1093/gerona/glw142. View

Palella Jr F, McKibben R, Post W, Li X, Budoff M, Kingsley L . Anatomic Fat Depots and Coronary Plaque Among Human Immunodeficiency Virus-Infected and Uninfected Men in the Multicenter AIDS Cohort Study. Open Forum Infect Dis. 2016; 3(2):ofw098. PMC: 4943560. DOI: 10.1093/ofid/ofw098. View

Piggott D, Varadhan R, Mehta S, Brown T, Li H, Walston J . Frailty, Inflammation, and Mortality Among Persons Aging With HIV Infection and Injection Drug Use. J Gerontol A Biol Sci Med Sci. 2015; 70(12):1542-7. PMC: 4643614. DOI: 10.1093/gerona/glv107. View

Erlandson K, Allshouse A, Jankowski C, MaWhinney S, Kohrt W, Campbell T . Functional impairment is associated with low bone and muscle mass among persons aging with HIV infection. J Acquir Immune Defic Syndr. 2013; 63(2):209-15. PMC: 3654048. DOI: 10.1097/QAI.0b013e318289bb7e. View

Kallianpur K, Sakoda M, Gangcuangco L, Ndhlovu L, Umaki T, Chow D . Frailty Characteristics in Chronic HIV Patients are Markers of White Matter Atrophy Independently of Age and Depressive Symptoms: A Pilot Study. Open Med J. 2016; 3:138-152. PMC: 5051693. DOI: 10.2174/1874220301603010138. View

Almansouri A, Abdulfatah M, Baaqil O, Bakheet A, Turki S, Kotb M . Serum Sclerostin Levels in Patients with Human Immunodeficiency Virus Infection and Their Association with Bone Turnover Markers and Bone Mineral Densitometry. J Bone Metab. 2016; 23(1):16-22. PMC: 4791433. DOI: 10.11005/jbm.2016.23.1.16. View

Cesari M, Leeuwenburgh C, Lauretani F, Onder G, Bandinelli S, Maraldi C . Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study. Am J Clin Nutr. 2006; 83(5):1142-8. PMC: 2668161. DOI: 10.1093/ajcn/83.5.1142. View

10.

Erlandson K, Ng D, Jacobson L, Margolick J, Dobs A, Palella Jr F . Inflammation, Immune Activation, Immunosenescence, and Hormonal Biomarkers in the Frailty-Related Phenotype of Men With or at Risk for HIV Infection. J Infect Dis. 2016; 215(2):228-237. PMC: 5897840. DOI: 10.1093/infdis/jiw523. View

11.

Gustafson D, Shi Q, Thurn M, Holman S, Minkoff H, Cohen M . Frailty and Constellations of Factors in Aging HIV-infected and Uninfected Women--The Women's Interagency HIV Study. J Frailty Aging. 2016; 5(1):43-8. PMC: 4957016. DOI: 10.14283/jfa.2016.79. View

12.

. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994; 843:1-129. View

13.

Desquilbet L, Jacobson L, Fried L, Phair J, Jamieson B, Holloway M . HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci. 2007; 62(11):1279-86. DOI: 10.1093/gerona/62.11.1279. View

14.

Terzian A, Holman S, Nathwani N, Robison E, Weber K, Young M . Factors associated with preclinical disability and frailty among HIV-infected and HIV-uninfected women in the era of cART. J Womens Health (Larchmt). 2010; 18(12):1965-74. PMC: 2828186. DOI: 10.1089/jwh.2008.1090. View

15.

Desquilbet L, Margolick J, Fried L, Phair J, Jamieson B, Holloway M . Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr. 2009; 50(3):299-306. PMC: 2699396. DOI: 10.1097/QAI.0b013e3181945eb0. View

16.

. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017; 4(8):e349-e356. PMC: 5555438. DOI: 10.1016/S2352-3018(17)30066-8. View

17.

Hubbard R, Lang I, Llewellyn D, Rockwood K . Frailty, body mass index, and abdominal obesity in older people. J Gerontol A Biol Sci Med Sci. 2009; 65(4):377-81. DOI: 10.1093/gerona/glp186. View

18.

Shah K, Hilton T, Myers L, Pinto J, Luque A, Hall W . A new frailty syndrome: central obesity and frailty in older adults with the human immunodeficiency virus. J Am Geriatr Soc. 2012; 60(3):545-9. PMC: 3302930. DOI: 10.1111/j.1532-5415.2011.03819.x. View

19.

Fielding R, Vellas B, Evans W, Bhasin S, Morley J, Newman A . Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011; 12(4):249-56. PMC: 3377163. DOI: 10.1016/j.jamda.2011.01.003. View

20.

Erlandson K, Wu K, Koletar S, Kalayjian R, Ellis R, Taiwo B . Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy. J Infect Dis. 2017; 215(6):933-937. PMC: 5407051. DOI: 10.1093/infdis/jix063. View